Analysts Set The Cooper Companies, Inc. (NASDAQ:COO) PT at $90.79

Shares of The Cooper Companies, Inc. (NASDAQ:COO) have been given an average rating of “Moderate Buy” by the seventeen analysts that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, eight have assigned a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $88.6429.

A number of equities analysts recently weighed in on COO shares. Barclays upped their target price on shares of Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, March 6th. Needham & Company LLC upped their target price on shares of Cooper Companies from $99.00 to $101.00 and gave the stock a “buy” rating in a research report on Friday, March 6th. Citigroup restated a “neutral” rating and set a $69.00 target price (down from $80.00) on shares of Cooper Companies in a research report on Thursday. Rothschild & Co Redburn lowered shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price for the company. in a research report on Wednesday, March 4th. Finally, Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th.

Cooper Companies Stock Performance

COO opened at $61.21 on Friday. The firm has a market cap of $11.94 billion, a P/E ratio of 30.30, a PEG ratio of 1.58 and a beta of 0.89. Cooper Companies has a 1-year low of $58.89 and a 1-year high of $89.83. The company has a 50 day simple moving average of $65.96 and a two-hundred day simple moving average of $74.87. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $1.03 by $0.07. The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The company’s revenue was up 6.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.92 earnings per share. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Equities analysts forecast that Cooper Companies will post 4.62 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Cooper Companies

A number of hedge funds and other institutional investors have recently modified their holdings of COO. Root Financial Partners LLC boosted its position in shares of Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after acquiring an additional 162 shares during the last quarter. SJS Investment Consulting Inc. boosted its position in shares of Cooper Companies by 107.5% during the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after acquiring an additional 187 shares during the last quarter. Bell Investment Advisors Inc boosted its position in shares of Cooper Companies by 106.3% during the third quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after acquiring an additional 219 shares during the last quarter. CYBER HORNET ETFs LLC purchased a new stake in Cooper Companies during the second quarter valued at $36,000. Finally, True Wealth Design LLC raised its stake in Cooper Companies by 484.8% during the fourth quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock valued at $38,000 after purchasing an additional 383 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.